Form D · Pharmaceuticals
LANNETT CO INC
Philadelphia, PA · CIK 0000057725
Offering snapshot reported May 7, 2021 · SEC filing
- Reported sold
- $28M Indefinite offering
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 22, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 7, 2021 | Initial | $27,962,307 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-398587
Source: Form D, filed May 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John M. Abt | Executive |
| Maureen M. Cavanaugh | Executive |
| John C. Chapman | Director |
| Timothy C. Crew | Director, Executive |
| David Drabik | Director |
| Robert Ehlinger | Executive |
| Jeffrey Farber | Director |
| Samuel H. Israel | Executive |
| John Kozlowski | Executive |
| Patrick G. Le Pore | Director |
| Melissa Rewolinski | Director |
| Paul Taveira | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9000 State Road
Philadelphia, PA, 19136
Philadelphia, PA, 19136